Correlation Between Millennium Pharmacon and Multifiling Mitra

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Millennium Pharmacon and Multifiling Mitra at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Millennium Pharmacon and Multifiling Mitra into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Millennium Pharmacon International and Multifiling Mitra Indonesia, you can compare the effects of market volatilities on Millennium Pharmacon and Multifiling Mitra and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Millennium Pharmacon with a short position of Multifiling Mitra. Check out your portfolio center. Please also check ongoing floating volatility patterns of Millennium Pharmacon and Multifiling Mitra.

Diversification Opportunities for Millennium Pharmacon and Multifiling Mitra

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Millennium and Multifiling is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Millennium Pharmacon Internati and Multifiling Mitra Indonesia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Multifiling Mitra and Millennium Pharmacon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Millennium Pharmacon International are associated (or correlated) with Multifiling Mitra. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Multifiling Mitra has no effect on the direction of Millennium Pharmacon i.e., Millennium Pharmacon and Multifiling Mitra go up and down completely randomly.

Pair Corralation between Millennium Pharmacon and Multifiling Mitra

Assuming the 90 days trading horizon Millennium Pharmacon is expected to generate 1.51 times less return on investment than Multifiling Mitra. But when comparing it to its historical volatility, Millennium Pharmacon International is 1.31 times less risky than Multifiling Mitra. It trades about 0.15 of its potential returns per unit of risk. Multifiling Mitra Indonesia is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  91,000  in Multifiling Mitra Indonesia on August 26, 2024 and sell it today you would earn a total of  34,000  from holding Multifiling Mitra Indonesia or generate 37.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.45%
ValuesDaily Returns

Millennium Pharmacon Internati  vs.  Multifiling Mitra Indonesia

 Performance 
       Timeline  
Millennium Pharmacon 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Millennium Pharmacon International are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting forward-looking signals, Millennium Pharmacon disclosed solid returns over the last few months and may actually be approaching a breakup point.
Multifiling Mitra 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Multifiling Mitra Indonesia are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting forward-looking signals, Multifiling Mitra disclosed solid returns over the last few months and may actually be approaching a breakup point.

Millennium Pharmacon and Multifiling Mitra Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Millennium Pharmacon and Multifiling Mitra

The main advantage of trading using opposite Millennium Pharmacon and Multifiling Mitra positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Millennium Pharmacon position performs unexpectedly, Multifiling Mitra can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Multifiling Mitra will offset losses from the drop in Multifiling Mitra's long position.
The idea behind Millennium Pharmacon International and Multifiling Mitra Indonesia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Transaction History
View history of all your transactions and understand their impact on performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years